Three-dimensional cell-scaffold constructs promote efficient gene transfection: Implications for cell-based gene therapy

被引:68
|
作者
Xie, YB
Yang, ST
Kniss, DA
机构
[1] Ohio State Univ, Coll Med & Publ Hlth, Dept Obstet & Gynecol, Div Maternal Fetal Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med & Publ Hlth, Dept Obstet & Gynecol, Lab Perinatal Res, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Med & Publ Hlth, Dept Chem Engn, Columbus, OH 43210 USA
[4] Ohio State Univ, Coll Engn, Columbus, OH 43210 USA
来源
TISSUE ENGINEERING | 2001年 / 7卷 / 05期
关键词
D O I
10.1089/107632701753213200
中图分类号
Q813 [细胞工程];
学科分类号
摘要
To date, introduction of gene-modified cells in vivo is still a critical limitation for cell-based gene therapy. In this study, based on tissue engineering techniques, we developed a three-dimensional (3-D) transfection system to be cell-based gene delivery vehicle. Human trophoblast-like ED27 and fibroblastic NIH3T3 cells were used as model cell lines. Cells were seeded onto PET fibrous matrices and plated on polyethylene terephathalate (PET) films as 2-D transfection control. The cell-matrices and cell-films were transfected with pCMV-beta gal and pEGFP (green fluorescent protein) reporter gene vectors using LipofectAmine(R) reagent. Gene expression on 3-D versus 2-D growth surface were investigated. The effects of seeding method, seeding density, porosity of the PET matrix, and culturing time of the cell-matrix complex on cDNA transfection and expression in the 3-D cell-matrix complex were also investigated. The beta -gal assay and GFP detection showed that 3-D transfection promoted a higher gene expression level and longer expression time as compared to 2-D transfection. There existed an optimal initial cell seeding density for gene transfection of 3-D cell-matrix complex. Cells seeded on PET matrices with a lower porosity (similar to 87%) had higher gene expression activities than cells in the matrices with a higher porosity (similar to 90%). Also, Higher gene expression levels of beta -gal were obtained for the more uniformly seeded matrices that were seeded with a depth-filtration method. The results from this study demonstrate the potential utility of cells seeded onto 3-D fibrous matrices as cell-based gene delivery vehicle for in vitro study of gene expression or in vivo gene therapy.
引用
收藏
页码:585 / 598
页数:14
相关论文
共 50 条
  • [41] Neural Stem Cell-based Gene Therapy for Brain Tumors
    Seung U. Kim
    Stem Cell Reviews and Reports, 2011, 7 : 130 - 140
  • [42] Endothelial cell-based systemic gene therapy of metastatic melanoma
    Ojeifo, JO
    Lee, HR
    Rezza, P
    Su, N
    Zwiebel, JA
    CANCER GENE THERAPY, 2001, 8 (09) : 636 - 648
  • [43] Cell-based delivery of a prostate cancer suicide gene therapy
    Martiniello-Wilks, R.
    Larsen, S. R.
    Tiffen, J. C.
    Bailey, C. G.
    Rasko, J. E. J.
    HUMAN GENE THERAPY, 2008, 19 (04) : 401 - 401
  • [44] Mesenchymal stem cell-based gene therapy for erectile dysfunction
    Kim, J. H.
    Lee, H. J.
    Song, Y. S.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2016, 28 (03) : 81 - 87
  • [45] Mesenchymal stem cell-based gene therapy for erectile dysfunction
    J H Kim
    H J Lee
    Y S Song
    International Journal of Impotence Research, 2016, 28 : 81 - 87
  • [46] Cell-Based Gene Therapy Is New Option for Multiple Myeloma
    Voelker, Rebecca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (17): : 1713 - 1713
  • [47] Gene Delivery in Three-Dimensional Cell Cultures by Superparamagnetic Nanoparticles
    Zhang, Haiyuan
    Lee, Moo-Yeal
    Hogg, Michael G.
    Dordick, Jonathan S.
    Sharfstein, Susan T.
    ACS NANO, 2010, 4 (08) : 4733 - 4743
  • [48] Manipulation of the tumor microenvironment by cytokine gene transfection enhances dendritic cell-based immunotherapy
    Wijesekera, Daluthgamage Patsy Himali
    Yuba, Eiji
    De Silva, Nadeeka Harshini
    Watanabe, Shun-ichi
    Tsukamoto, Masaya
    Ichida, Chihiro
    Izawa, Takeshi
    Itoh, Kazuyuki
    Kanegi, Ryoji
    Hatoya, Shingo
    Yamate, Jyoji
    Inaba, Toshio
    Sugiura, Kikuya
    FASEB BIOADVANCES, 2020, 2 (01) : 5 - 17
  • [49] HEMATOPOIETIC STEM CELL-BASED GENE-THERAPY OF AIDS
    PLAVEC, I
    ESCAICH, S
    RIGG, R
    DIGIUSTO, D
    BOHNLEIN, E
    JUNKER, U
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S155 - S155
  • [50] Cell-based gene therapy for the prevention and treatment of cardiac dysfunction
    Penn M.S.
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (Suppl 1): : S83 - S88